Burn and Scald Medicine Market is projected to reach USD $ Billion in 2025, at a $% CAGR by driving industry size, share, segments research, top cpany analysis, trends and forecast report 2025 to 2031.

Burn and Scald Medicine Market Growth and Outlook 2025-2031

The global Burn and Scald Medicine market size is predicted to grow from US$ 4641 million in 2025 to US$ 6286 million in 2031; it is expected to grow at a CAGR of 5.2% from 2025 to 2031.Burn and scald medicine refers to a kind of medicine used to treat skin and tissue damage caused by heat, chemical substances, electric shock or radiation. These drugs are designed to reduce pain, prevent infection, promote wound healing, and minimize scar formation, focusing on the most commonly used burn wound dressings and topical drugs in adults and children.United States market for Burn and Scald Medicine is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.China market for Burn and Scald Medicine is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.Europe market for Burn and Scald Medicine is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.Global key Burn and Scald Medicine players cover Nipro, MediWound, STADA Arzneimittel, Elastoplast, Pfizer, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.LPI (LP Information)' newest research report, the &ldquo;Burn and Scald Medicine Industry Forecast&rdquo; looks at past sales and reviews total world Burn and Scald Medicine sales in 2024, providing a comprehensive analysis by region and market sector of projected Burn and Scald Medicine sales for 2025 through 2031. With Burn and Scald Medicine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Burn and Scald Medicine industry.This Insight Report provides a comprehensive analysis of the global Burn and Scald Medicine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&amp;A activity. This report also analyses the strategies of leading global companies with a focus on Burn and Scald Medicine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms&rsquo; unique position in an accelerating global Burn and Scald Medicine market.This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Burn and Scald Medicine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Burn and Scald Medicine.This report presents a comprehensive overview, market shares, and growth opportunities of Burn and Scald Medicine market by product type, application, key players and key regions and countries.Segmentation by Type:&nbsp;&nbsp;&nbsp; Dressing &nbsp;&nbsp;&nbsp; Ointment &nbsp;&nbsp;&nbsp; SpraySegmentation by Application:&nbsp;&nbsp;&nbsp; Hospital &nbsp;&nbsp;&nbsp; Clinic &nbsp;&nbsp;&nbsp; Pharmacy &nbsp;&nbsp;&nbsp; OnlineThis report also splits the market by region:&nbsp;&nbsp;&nbsp; Americas&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil&nbsp;&nbsp;&nbsp; APAC&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia&nbsp;&nbsp;&nbsp; Europe&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia&nbsp;&nbsp;&nbsp; Middle East &amp; Africa&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC CountriesThe below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.&nbsp;&nbsp;&nbsp; Nipro &nbsp;&nbsp;&nbsp; MediWound &nbsp;&nbsp;&nbsp; STADA Arzneimittel &nbsp;&nbsp;&nbsp; Elastoplast &nbsp;&nbsp;&nbsp; Pfizer &nbsp;&nbsp;&nbsp; Bharat Biotech &nbsp;&nbsp;&nbsp; Paul Hartmann &nbsp;&nbsp;&nbsp; Ono Pharmaceutical &nbsp;&nbsp;&nbsp; Centaur Pharmaceuticals &nbsp;&nbsp;&nbsp; Kedrion Biopharma &nbsp;&nbsp;&nbsp; Smith &amp; Nephew &nbsp;&nbsp;&nbsp; ConvaTec &nbsp;&nbsp;&nbsp; B. Braun Melsungen &nbsp;&nbsp;&nbsp; Coloplast &nbsp;&nbsp;&nbsp; M&ouml;lnlycke Health Care &nbsp;&nbsp;&nbsp; Medline Industries &nbsp;&nbsp;&nbsp; Hartmann &nbsp;&nbsp;&nbsp; Ferndale Pharmaceuticals &nbsp;&nbsp;&nbsp; Guizhou Jingcheng Medicine &nbsp;&nbsp;&nbsp; Mebo Pharmaceutical Technology &nbsp;&nbsp;&nbsp; Shanghai Tenry Pharm &nbsp;&nbsp;&nbsp; Guilin Huanuo Gene Pharmaceutical &nbsp;&nbsp;&nbsp; Shanghai Haohai Biotechnology &nbsp;&nbsp;&nbsp; Beijing SL Pharmaceutical &nbsp;&nbsp;&nbsp; Hubei Mayinglong Pharmaceutical &nbsp;&nbsp;&nbsp; Jianmin Group &nbsp;&nbsp;&nbsp; Tianjin Pharm Group &nbsp;&nbsp;&nbsp; Cardinal Health &nbsp;&nbsp;&nbsp; Integra LifeSciences &nbsp;&nbsp;&nbsp; Deroyal &nbsp;&nbsp;&nbsp; DermaRite Industries

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global Burn and Scald Medicine Market Size (2020-2031) &nbsp;2.1.2 Burn and Scald Medicine Market Size CAGR by Region (2020 VS 2024 VS 2031) &nbsp;2.1.3 World Current &amp; Future Analysis for Burn and Scald Medicine by Country/Region (2020, 2024 &amp; 2031) &nbsp;2.2 Burn and Scald Medicine Segment by Type &nbsp;2.2.1 Dressing &nbsp;2.2.2 Ointment &nbsp;2.2.3 Spray &nbsp;2.3 Burn and Scald Medicine Market Size by Type &nbsp;2.3.1 Burn and Scald Medicine Market Size CAGR by Type (2020 VS 2024 VS 2031) &nbsp;2.3.2 Global Burn and Scald Medicine Market Size Market Share by Type (2020-2025) &nbsp;2.4 Burn and Scald Medicine Segment by Application &nbsp;2.4.1 Hospital &nbsp;2.4.2 Clinic &nbsp;2.4.3 Pharmacy &nbsp;2.4.4 Online &nbsp;2.5 Burn and Scald Medicine Market Size by Application &nbsp;2.5.1 Burn and Scald Medicine Market Size CAGR by Application (2020 VS 2024 VS 2031) &nbsp;2.5.2 Global Burn and Scald Medicine Market Size Market Share by Application (2020-2025)3 Burn and Scald Medicine Market Size by Player &nbsp;3.1 Burn and Scald Medicine Market Size Market Share by Player &nbsp;3.1.1 Global Burn and Scald Medicine Revenue by Player (2020-2025) &nbsp;3.1.2 Global Burn and Scald Medicine Revenue Market Share by Player (2020-2025) &nbsp;3.2 Global Burn and Scald Medicine Key Players Head office and Products Offered &nbsp;3.3 Market Concentration Rate Analysis &nbsp;3.3.1 Competition Landscape Analysis &nbsp;3.3.2 Concentration Ratio (CR3, CR5 and CR10) &amp; (2023-2025) &nbsp;3.4 New Products and Potential Entrants &nbsp;3.5 Mergers &amp; Acquisitions, Expansion4 Burn and Scald Medicine by Region &nbsp;4.1 Burn and Scald Medicine Market Size by Region (2020-2025) &nbsp;4.2 Global Burn and Scald Medicine Annual Revenue by Country/Region (2020-2025) &nbsp;4.3 Americas Burn and Scald Medicine Market Size Growth (2020-2025) &nbsp;4.4 APAC Burn and Scald Medicine Market Size Growth (2020-2025) &nbsp;4.5 Europe Burn and Scald Medicine Market Size Growth (2020-2025) &nbsp;4.6 Middle East &amp; Africa Burn and Scald Medicine Market Size Growth (2020-2025)5 Americas &nbsp;5.1 Americas Burn and Scald Medicine Market Size by Country (2020-2025) &nbsp;5.2 Americas Burn and Scald Medicine Market Size by Type (2020-2025) &nbsp;5.3 Americas Burn and Scald Medicine Market Size by Application (2020-2025) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil6 APAC &nbsp;6.1 APAC Burn and Scald Medicine Market Size by Region (2020-2025) &nbsp;6.2 APAC Burn and Scald Medicine Market Size by Type (2020-2025) &nbsp;6.3 APAC Burn and Scald Medicine Market Size by Application (2020-2025) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia7 Europe &nbsp;7.1 Europe Burn and Scald Medicine Market Size by Country (2020-2025) &nbsp;7.2 Europe Burn and Scald Medicine Market Size by Type (2020-2025) &nbsp;7.3 Europe Burn and Scald Medicine Market Size by Application (2020-2025) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia8 Middle East &amp; Africa &nbsp;8.1 Middle East &amp; Africa Burn and Scald Medicine by Region (2020-2025) &nbsp;8.2 Middle East &amp; Africa Burn and Scald Medicine Market Size by Type (2020-2025) &nbsp;8.3 Middle East &amp; Africa Burn and Scald Medicine Market Size by Application (2020-2025) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers &amp; Growth Opportunities &nbsp;9.2 Market Challenges &amp; Risks &nbsp;9.3 Industry Trends10 Global Burn and Scald Medicine Market Forecast &nbsp;10.1 Global Burn and Scald Medicine Forecast by Region (2026-2031) &nbsp;10.1.1 Global Burn and Scald Medicine Forecast by Region (2026-2031) &nbsp;10.1.2 Americas Burn and Scald Medicine Forecast &nbsp;10.1.3 APAC Burn and Scald Medicine Forecast &nbsp;10.1.4 Europe Burn and Scald Medicine Forecast &nbsp;10.1.5 Middle East &amp; Africa Burn and Scald Medicine Forecast &nbsp;10.2 Americas Burn and Scald Medicine Forecast by Country (2026-2031) &nbsp;10.2.1 United States Market Burn and Scald Medicine Forecast &nbsp;10.2.2 Canada Market Burn and Scald Medicine Forecast &nbsp;10.2.3 Mexico Market Burn and Scald Medicine Forecast &nbsp;10.2.4 Brazil Market Burn and Scald Medicine Forecast &nbsp;10.3 APAC Burn and Scald Medicine Forecast by Region (2026-2031) &nbsp;10.3.1 China Burn and Scald Medicine Market Forecast &nbsp;10.3.2 Japan Market Burn and Scald Medicine Forecast &nbsp;10.3.3 Korea Market Burn and Scald Medicine Forecast &nbsp;10.3.4 Southeast Asia Market Burn and Scald Medicine Forecast &nbsp;10.3.5 India Market Burn and Scald Medicine Forecast &nbsp;10.3.6 Australia Market Burn and Scald Medicine Forecast &nbsp;10.4 Europe Burn and Scald Medicine Forecast by Country (2026-2031) &nbsp;10.4.1 Germany Market Burn and Scald Medicine Forecast &nbsp;10.4.2 France Market Burn and Scald Medicine Forecast &nbsp;10.4.3 UK Market Burn and Scald Medicine Forecast &nbsp;10.4.4 Italy Market Burn and Scald Medicine Forecast &nbsp;10.4.5 Russia Market Burn and Scald Medicine Forecast &nbsp;10.5 Middle East &amp; Africa Burn and Scald Medicine Forecast by Region (2026-2031) &nbsp;10.5.1 Egypt Market Burn and Scald Medicine Forecast &nbsp;10.5.2 South Africa Market Burn and Scald Medicine Forecast &nbsp;10.5.3 Israel Market Burn and Scald Medicine Forecast &nbsp;10.5.4 Turkey Market Burn and Scald Medicine Forecast &nbsp;10.6 Global Burn and Scald Medicine Forecast by Type (2026-2031) &nbsp;10.7 Global Burn and Scald Medicine Forecast by Application (2026-2031) &nbsp;10.7.1 GCC Countries Market Burn and Scald Medicine Forecast11 Key Players Analysis &nbsp;11.1 Nipro &nbsp;11.1.1 Nipro Company Information &nbsp;11.1.2 Nipro Burn and Scald Medicine Product Offered &nbsp;11.1.3 Nipro Burn and Scald Medicine Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.1.4 Nipro Main Business Overview &nbsp;11.1.5 Nipro Latest Developments &nbsp;11.2 MediWound &nbsp;11.2.1 MediWound Company Information &nbsp;11.2.2 MediWound Burn and Scald Medicine Product Offered &nbsp;11.2.3 MediWound Burn and Scald Medicine Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.2.4 MediWound Main Business Overview &nbsp;11.2.5 MediWound Latest Developments &nbsp;11.3 STADA Arzneimittel &nbsp;11.3.1 STADA Arzneimittel Company Information &nbsp;11.3.2 STADA Arzneimittel Burn and Scald Medicine Product Offered &nbsp;11.3.3 STADA Arzneimittel Burn and Scald Medicine Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.3.4 STADA Arzneimittel Main Business Overview &nbsp;11.3.5 STADA Arzneimittel Latest Developments &nbsp;11.4 Elastoplast &nbsp;11.4.1 Elastoplast Company Information &nbsp;11.4.2 Elastoplast Burn and Scald Medicine Product Offered &nbsp;11.4.3 Elastoplast Burn and Scald Medicine Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.4.4 Elastoplast Main Business Overview &nbsp;11.4.5 Elastoplast Latest Developments &nbsp;11.5 Pfizer &nbsp;11.5.1 Pfizer Company Information &nbsp;11.5.2 Pfizer Burn and Scald Medicine Product Offered &nbsp;11.5.3 Pfizer Burn and Scald Medicine Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.5.4 Pfizer Main Business Overview &nbsp;11.5.5 Pfizer Latest Developments &nbsp;11.6 Bharat Biotech &nbsp;11.6.1 Bharat Biotech Company Information &nbsp;11.6.2 Bharat Biotech Burn and Scald Medicine Product Offered &nbsp;11.6.3 Bharat Biotech Burn and Scald Medicine Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.6.4 Bharat Biotech Main Business Overview &nbsp;11.6.5 Bharat Biotech Latest Developments &nbsp;11.7 Paul Hartmann &nbsp;11.7.1 Paul Hartmann Company Information &nbsp;11.7.2 Paul Hartmann Burn and Scald Medicine Product Offered &nbsp;11.7.3 Paul Hartmann Burn and Scald Medicine Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.7.4 Paul Hartmann Main Business Overview &nbsp;11.7.5 Paul Hartmann Latest Developments &nbsp;11.8 Ono Pharmaceutical &nbsp;11.8.1 Ono Pharmaceutical Company Information &nbsp;11.8.2 Ono Pharmaceutical Burn and Scald Medicine Product Offered &nbsp;11.8.3 Ono Pharmaceutical Burn and Scald Medicine Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.8.4 Ono Pharmaceutical Main Business Overview &nbsp;11.8.5 Ono Pharmaceutical Latest Developments &nbsp;11.9 Centaur Pharmaceuticals &nbsp;11.9.1 Centaur Pharmaceuticals Company Information &nbsp;11.9.2 Centaur Pharmaceuticals Burn and Scald Medicine Product Offered &nbsp;11.9.3 Centaur Pharmaceuticals Burn and Scald Medicine Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.9.4 Centaur Pharmaceuticals Main Business Overview &nbsp;11.9.5 Centaur Pharmaceuticals Latest Developments &nbsp;11.10 Kedrion Biopharma &nbsp;11.10.1 Kedrion Biopharma Company Information &nbsp;11.10.2 Kedrion Biopharma Burn and Scald Medicine Product Offered &nbsp;11.10.3 Kedrion Biopharma Burn and Scald Medicine Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.10.4 Kedrion Biopharma Main Business Overview &nbsp;11.10.5 Kedrion Biopharma Latest Developments &nbsp;11.11 Smith &amp; Nephew &nbsp;11.11.1 Smith &amp; Nephew Company Information &nbsp;11.11.2 Smith &amp; Nephew Burn and Scald Medicine Product Offered &nbsp;11.11.3 Smith &amp; Nephew Burn and Scald Medicine Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.11.4 Smith &amp; Nephew Main Business Overview &nbsp;11.11.5 Smith &amp; Nephew Latest Developments &nbsp;11.12 ConvaTec &nbsp;11.12.1 ConvaTec Company Information &nbsp;11.12.2 ConvaTec Burn and Scald Medicine Product Offered &nbsp;11.12.3 ConvaTec Burn and Scald Medicine Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.12.4 ConvaTec Main Business Overview &nbsp;11.12.5 ConvaTec Latest Developments &nbsp;11.13 B. Braun Melsungen &nbsp;11.13.1 B. Braun Melsungen Company Information &nbsp;11.13.2 B. Braun Melsungen Burn and Scald Medicine Product Offered &nbsp;11.13.3 B. Braun Melsungen Burn and Scald Medicine Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.13.4 B. Braun Melsungen Main Business Overview &nbsp;11.13.5 B. Braun Melsungen Latest Developments &nbsp;11.14 Coloplast &nbsp;11.14.1 Coloplast Company Information &nbsp;11.14.2 Coloplast Burn and Scald Medicine Product Offered &nbsp;11.14.3 Coloplast Burn and Scald Medicine Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.14.4 Coloplast Main Business Overview &nbsp;11.14.5 Coloplast Latest Developments &nbsp;11.15 M&ouml;lnlycke Health Care &nbsp;11.15.1 M&ouml;lnlycke Health Care Company Information &nbsp;11.15.2 M&ouml;lnlycke Health Care Burn and Scald Medicine Product Offered &nbsp;11.15.3 M&ouml;lnlycke Health Care Burn and Scald Medicine Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.15.4 M&ouml;lnlycke Health Care Main Business Overview &nbsp;11.15.5 M&ouml;lnlycke Health Care Latest Developments &nbsp;11.16 Medline Industries &nbsp;11.16.1 Medline Industries Company Information &nbsp;11.16.2 Medline Industries Burn and Scald Medicine Product Offered &nbsp;11.16.3 Medline Industries Burn and Scald Medicine Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.16.4 Medline Industries Main Business Overview &nbsp;11.16.5 Medline Industries Latest Developments &nbsp;11.17 Hartmann &nbsp;11.17.1 Hartmann Company Information &nbsp;11.17.2 Hartmann Burn and Scald Medicine Product Offered &nbsp;11.17.3 Hartmann Burn and Scald Medicine Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.17.4 Hartmann Main Business Overview &nbsp;11.17.5 Hartmann Latest Developments &nbsp;11.18 Ferndale Pharmaceuticals &nbsp;11.18.1 Ferndale Pharmaceuticals Company Information &nbsp;11.18.2 Ferndale Pharmaceuticals Burn and Scald Medicine Product Offered &nbsp;11.18.3 Ferndale Pharmaceuticals Burn and Scald Medicine Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.18.4 Ferndale Pharmaceuticals Main Business Overview &nbsp;11.18.5 Ferndale Pharmaceuticals Latest Developments &nbsp;11.19 Guizhou Jingcheng Medicine &nbsp;11.19.1 Guizhou Jingcheng Medicine Company Information &nbsp;11.19.2 Guizhou Jingcheng Medicine Burn and Scald Medicine Product Offered &nbsp;11.19.3 Guizhou Jingcheng Medicine Burn and Scald Medicine Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.19.4 Guizhou Jingcheng Medicine Main Business Overview &nbsp;11.19.5 Guizhou Jingcheng Medicine Latest Developments &nbsp;11.20 Mebo Pharmaceutical Technology &nbsp;11.20.1 Mebo Pharmaceutical Technology Company Information &nbsp;11.20.2 Mebo Pharmaceutical Technology Burn and Scald Medicine Product Offered &nbsp;11.20.3 Mebo Pharmaceutical Technology Burn and Scald Medicine Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.20.4 Mebo Pharmaceutical Technology Main Business Overview &nbsp;11.20.5 Mebo Pharmaceutical Technology Latest Developments &nbsp;11.21 Shanghai Tenry Pharm &nbsp;11.21.1 Shanghai Tenry Pharm Company Information &nbsp;11.21.2 Shanghai Tenry Pharm Burn and Scald Medicine Product Offered &nbsp;11.21.3 Shanghai Tenry Pharm Burn and Scald Medicine Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.21.4 Shanghai Tenry Pharm Main Business Overview &nbsp;11.21.5 Shanghai Tenry Pharm Latest Developments &nbsp;11.22 Guilin Huanuo Gene Pharmaceutical &nbsp;11.22.1 Guilin Huanuo Gene Pharmaceutical Company Information &nbsp;11.22.2 Guilin Huanuo Gene Pharmaceutical Burn and Scald Medicine Product Offered &nbsp;11.22.3 Guilin Huanuo Gene Pharmaceutical Burn and Scald Medicine Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.22.4 Guilin Huanuo Gene Pharmaceutical Main Business Overview &nbsp;11.22.5 Guilin Huanuo Gene Pharmaceutical Latest Developments &nbsp;11.23 Shanghai Haohai Biotechnology &nbsp;11.23.1 Shanghai Haohai Biotechnology Company Information &nbsp;11.23.2 Shanghai Haohai Biotechnology Burn and Scald Medicine Product Offered &nbsp;11.23.3 Shanghai Haohai Biotechnology Burn and Scald Medicine Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.23.4 Shanghai Haohai Biotechnology Main Business Overview &nbsp;11.23.5 Shanghai Haohai Biotechnology Latest Developments &nbsp;11.24 Beijing SL Pharmaceutical &nbsp;11.24.1 Beijing SL Pharmaceutical Company Information &nbsp;11.24.2 Beijing SL Pharmaceutical Burn and Scald Medicine Product Offered &nbsp;11.24.3 Beijing SL Pharmaceutical Burn and Scald Medicine Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.24.4 Beijing SL Pharmaceutical Main Business Overview &nbsp;11.24.5 Beijing SL Pharmaceutical Latest Developments &nbsp;11.25 Hubei Mayinglong Pharmaceutical &nbsp;11.25.1 Hubei Mayinglong Pharmaceutical Company Information &nbsp;11.25.2 Hubei Mayinglong Pharmaceutical Burn and Scald Medicine Product Offered &nbsp;11.25.3 Hubei Mayinglong Pharmaceutical Burn and Scald Medicine Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.25.4 Hubei Mayinglong Pharmaceutical Main Business Overview &nbsp;11.25.5 Hubei Mayinglong Pharmaceutical Latest Developments &nbsp;11.26 Jianmin Group &nbsp;11.26.1 Jianmin Group Company Information &nbsp;11.26.2 Jianmin Group Burn and Scald Medicine Product Offered &nbsp;11.26.3 Jianmin Group Burn and Scald Medicine Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.26.4 Jianmin Group Main Business Overview &nbsp;11.26.5 Jianmin Group Latest Developments &nbsp;11.27 Tianjin Pharm Group &nbsp;11.27.1 Tianjin Pharm Group Company Information &nbsp;11.27.2 Tianjin Pharm Group Burn and Scald Medicine Product Offered &nbsp;11.27.3 Tianjin Pharm Group Burn and Scald Medicine Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.27.4 Tianjin Pharm Group Main Business Overview &nbsp;11.27.5 Tianjin Pharm Group Latest Developments &nbsp;11.28 Cardinal Health &nbsp;11.28.1 Cardinal Health Company Information &nbsp;11.28.2 Cardinal Health Burn and Scald Medicine Product Offered &nbsp;11.28.3 Cardinal Health Burn and Scald Medicine Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.28.4 Cardinal Health Main Business Overview &nbsp;11.28.5 Cardinal Health Latest Developments &nbsp;11.29 Integra LifeSciences &nbsp;11.29.1 Integra LifeSciences Company Information &nbsp;11.29.2 Integra LifeSciences Burn and Scald Medicine Product Offered &nbsp;11.29.3 Integra LifeSciences Burn and Scald Medicine Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.29.4 Integra LifeSciences Main Business Overview &nbsp;11.29.5 Integra LifeSciences Latest Developments &nbsp;11.30 Deroyal &nbsp;11.30.1 Deroyal Company Information &nbsp;11.30.2 Deroyal Burn and Scald Medicine Product Offered &nbsp;11.30.3 Deroyal Burn and Scald Medicine Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.30.4 Deroyal Main Business Overview &nbsp;11.30.5 Deroyal Latest Developments &nbsp;11.31 DermaRite Industries &nbsp;11.31.1 DermaRite Industries Company Information &nbsp;11.31.2 DermaRite Industries Burn and Scald Medicine Product Offered &nbsp;11.31.3 DermaRite Industries Burn and Scald Medicine Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.31.4 DermaRite Industries Main Business Overview &nbsp;11.31.5 DermaRite Industries Latest Developments 12 Research Findings and Conclusion

Report	Global Burn and Scald Medicine Market Growth (Status and Outlook) 2025-2031
Selected License	Multi ID: LPI2690

Buyer Information

Order Summary